The mitochondria-targeted antioxidant MitoQ modulates oxidative stress, inflammation and leukocyte-endothelium interactions in leukocytes isolated from type 2 diabetic patients

Redox Biology

Volumn 10, Issue , 2016, Pages 200-205

  Escribano Lopez, Irene ^a   Diaz Morales, Noelia ^a   Rovira Llopis, Susana ^a,b   de Marañon, Arantxa Martinez ^a   Orden, Samuel ^b   Alvarez, Angeles ^b   Bañuls, Celia ^a,b   Rocha, Milagros ^a,b   Murphy, Michael P ^c   Hernandez Mijares, Antonio ^a,b   Victor, Victor M ^a,b  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Endothelium; Inflammation; Leukocytes; MitoQ; Oxidative stress; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; ANTIOXIDANT; C REACTIVE PROTEIN; GLUCOSE; GLUTATHIONE PEROXIDASE 1; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; MITOQUINONE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR RELA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; GLUTATHIONE PEROXIDASE; ORGANOPHOSPHORUS COMPOUND; RELA PROTEIN, HUMAN; TNF PROTEIN, HUMAN; UBIQUINONE;

ADULT; ANTHROPOMETRIC PARAMETERS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CELL INTERACTION; CELL ISOLATION; CONTROLLED STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DISEASE ASSESSMENT; DRUG TARGETING; ENDOTHELIUM; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INSULIN BLOOD LEVEL; LEUKOCYTE; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT GAIN; AGED; ANALOGS AND DERIVATIVES; ANTHROPOMETRY; BLOOD; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

AGED; ANTHROPOMETRY; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; DIABETES MELLITUS, TYPE 2; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA; UBIQUINONE;

EID: 84994210526     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2016.10.017     Document Type: Article

References (43)

1. [1] Mittal, M., Siddiqui, M.R., Tran, K., Reddy, S.P., Malik, A.B., Reactive oxygen species in inflammation and tissue injury. Antioxid. Redox Signal 20 (2014), 1126–1167.
2. [2] Pickup, J.C., Mattock, M.B., Chusney, G.D., Burt, D., NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40 (1997), 1286–1292.
3. [3] Duncan, B.B., Schmidt, M.I., Pankow, J.S., Ballantyne, C.M., Couper, D., Vigo, A., Hoogeveen, R., Folsom, A.R., Heiss, G., atherosclerosis risk in communities study. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52 (2003), 1799–1805.
4. [4] Smitherman, K.O., Peacock, J.E., Infectious emergencies in patients with diabetes mellitus. Infect. Dis. Clin. N. Am. 9 (1995), 53–77.
5. [5] Yi, B., Hu, X., Zhang, H., Huang, J., Liu, J., Hu, J., Li, W., Huang, L., Nuclear NF-κB p65 in peripheral blood mononuclear cells correlates with urinary MCP-1, RANTES and the severity of type 2 diabetic nephropathy. PLoS One, 9, 2014, e99633.
6. [6] Malin, S.K., Kirwan, J.P., Sia, C.L., González, F., Pancreatic β-cell dysfunction in polycystic ovary syndrome: role of hyperglycemia-induced nuclear factor-κB activation and systemic inflammation. Am. J. Physiol. Endocrinol. Metab. 308 (2015), E770–E777.
7. [7] Galkina, E., Ley, K., Immune and inflammatory mechanisms of atherosclerosis. Annu Rev. Immunol. 27 (2009), 165–197.
8. [8] Boudina, S., Sena, S., O'Neill, B.T., Tathireddy, P., Young, M.E., Abel, E.D., Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112 (2005), 2686–2695.
9. [9] Hernandez-Mijares, A., Rocha, M., Apostolova, N., Borras, C., Jover, A., Bañuls, C., Sola, E., Victor, V.M., Mitochondrial complex I impairment in leukocytes from type 2 diabetic patients. Free Radic. Biol. Med. 50 (2011), 1215–1221.
10. [10] Sivitz, W.I., Yorek, M.A., Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid. Redox Signal 12 (2010), 537–577.
11. [11] Green, K., Brand, M.D., Murphy, M.P., Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 53 (2004), S110–S118.
12. [12] Edwards, J.L., Quattrini, A., Lentz, S.I., Figueroa-Romero, C., Cerri, F., Backus, C., Hong, Y., Feldman, E.L., Diabetes regulates mitochondrial biogenesis and fission in neurons. Diabetologia 53 (2010), 160–169.
13. [13] Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., Garg, R., Metabolic syndrome - a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111 (2005), 1448–1454.
14. [14] Kim, J.A., Wei, Y., Sowers, J.R., Role of mitochondrial dysfunction in insulin resistance. Circ. Res. 102 (2008), 401–414.
15. [15] James, A.M., Sharpley, M.S., Manas, A.R.B., Frerman, F.E., Hirst, J., Smith, R.A.J., Murphy, M.P., Interaction of the mitochondria targeted antioxidant MitoQ with phospholipid bilayers and ubiquinone oxidoreductases. J. Biol. Chem. 282 (2007), 14708–14718.
16. [16] Murphy, M.P., Smith, R.A.J., Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu. Rev. Pharm. 47 (2007), 629–656.
17. [17] Smith, R.A.J., Adlam, V.J., Blaikie, F.H., Manas, A.R.B., Porteous, C.M., James, A.M., Ross, M.F., Logan, A., Cocheme, H.M., Trnka, J., Prime, T.A., Abakumova, I., Jones, B.A., Filipovska, A., Murphy, M.P., Mitochondria-targeted antioxidants in the treatment of disease. Ann. N. Y. Acad. Sci. 1147 (2008), 105–111.
18. [18] Chacko, B.K., Reily, C., Srivastava, A., Johnson, M.S., Ye, Y.Z., Ulasova, E., Agarwal, A., Zinn, K.R., Murphy, M.P., Kalyanaraman, B., Darley-Usmar, V., Prevention of diabetic nephropathy in Ins2(+/)-(AkitaJ) mice by the mitochondria-targeted therapy MitoQ. Biochem. J. 432 (2010), 9–19.
19. [19] Lu, C., Zhang, D.W., Whiteman, M., Armstrong, J.S., Is antioxidant potential of the mitochondrial targeted ubiquinone derivative MitoQ conserved in cells lacking mtDNA?. Antioxid. Redox Signal. 10 (2008), 651–660.
20. [20] Apostolova, N., Victor, V.M., Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications. Antioxid. Redox Signal. 22 (2015), 686–729.
21. [21] Hernandez-Mijares, A., Rocha, M., Rovira-Llopis, S., Bañuls, C., Bellod, L., De Pablo, C., Alvarez, A., Roldan-Torres, I., Sola-Izquierdo, E., Victor, V.M., Human leukocyte/endothelial cell interactions and mitochondrial dysfunction in type 2 diabetic patients and their association with silent myocardial ischemia. Diabetes Care 36 (2013), 1695–1702.
22. [22] Rovira-Llopis, S., Bañuls, C., Apostolova, N., Morillas, C., Hernandez-Mijares, A., Rocha, M., Victor, V.M., Is glycemic control modulating endoplasmic reticulum stress in leukocytes of type 2 diabetic patients?. Antioxid. Redox Signal. 21 (2014), 1759–1765.
23. [23] Rovira-Llopis, S., Rocha, M., Falcon, R., de Pablo, C., Alvarez, A., Jover, A., Hernandez-Mijares, A., Victor, V.M., Is myeloperoxidase a key component in the ROS-induced vascular damage related to nephropathy in type 2 diabetes?. Antioxid. Redox Signal. 19 (2013), 1452–1458.
24. [24] Munusamy, S., MacMillan-Crow, L.A., Mitochondrial superoxide plays a crucial role in the development of Mitochondrial dysfunction during high glucose exposure in rat renal proximal tubular cells. Free Radic. Biol. Med. 46 (2009), 1149–1157.
25. [25] Kowluru, R.A., Kowluru, V., Xiong, Y., Ho, Y.S., Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Radic. Biol. Med. 41 (2006), 1191–1196.
26. [26] Dai, S., He, Y., Zhang, H., Yu, L., Wan, T., Xu, Z., Jones, D., Chen, H., Min, W., Endothelial-specific expression of mitochondrial thioredoxin promotes ischemia-mediated arteriogenesis and angiogenesis. Arterioscler Thromb. Vasc. Biol. 29 (2009), 495–502.
27. [27] Adlam, V.J., Harrison, J.C., Porteous, C.M., James, A.M., Smith, R.A., Murphy, M.P., Sammut, I.A., Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J. 19 (2005), 1088–1095.
28. [28] Esplugues, J.V., Rocha, M., Nuñez, C., Bosca, I., Ibiza, S., Herance, J.R., Ortega, A., Serrador, J.M., D'Ocon, P., Victor, V.M., Complex I dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-targeted antioxidants. Circ. Res. 99 (2006), 1067–1075.
29. [29] Graham, D., Huynh, N.N., Hamilton, C.A., Beattie, E., Smith, R.A., Cochemé, H.M., Murphy, M.P., Dominiczak, A.F., Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 54 (2009), 322–328.
30. [30] Coudray, C., Fouret, G., Lambert, K., Ferreri, C., Rieusset, J., Blachnio-Zabielska, A., Lecomte, J., Ebabe Elle, R., Badia, E., Murphy, M.P., Feillet-Coudray, C., A mitochondrial-targeted ubiquinone modulates muscle lipid profile and improves mitochondrial respiration in obesogenic diet-fed rats. Br. J. Nutr. 115 (2016), 1155–1166.
31. [31] Reily, C., Mitchell, T., Chacko, B.K., Benavides, G., Murphy, M.P., Darley-Usmar, V., Mitochondrially targeted compounds and their impact on cellular bioenergetics. Redox Biol.(1), 2013, 86–93.
32. [32] Giacco, F., Brownlee, M., Oxidative stress and diabetic complications. Circ. Res. 107 (2010), 1058–1070.
33. [33] Prieto, D., Contreras, C., Sánchez, A., Endothelial dysfunction, obesity and insulin resistance. Curr. Vasc. Pharm. 12 (2014), 412–426.
34. [34] Gallego-Villar, L., Pérez, B., Ugarte, M., Desviat, L.R., Richard, E., Antioxidants successfully reduce ROS production in propionic acidemia fibroblasts. Biochem Biophys. Res. Commun. 452:3 (2014), 457–461.
35. [35] Libby, P., Inflammation in atherosclerosis. Nature 420 (2002), 868–874.
36. [36] Victor, V.M., Rocha, M., Bañuls, C., Alvarez, A., de Pablo, C., Sanchez-Serrano, M., Gomez, M., Hernandez-Mijares, A., Induction of oxidative stress and human leukocyte/endothelial cell interactions in polycystic ovary syndrome patients with insulin resistance. J. Clin. Endocrinol. Metab. 96:10 (2011), 3115–3122.
37. [37] Dare, A.J., Logan, A., Prime, T.A., Rogatti, S., Goddard, M., Bolton, E.M., Bradley, J.A., Pettigrew, G.J., Murphy, M.P., Saeb-Parsy, K., The mitochondria-targeted anti-oxidant MitoQ decreases ischemia-reperfusion injury in a murine syngeneic heart transplant model. J. Heart Lung Transpl. 34 (2015), 1471–1480.
38. [38] Mercer, J.R., Yu, E., Figg, N., Cheng, K.K., Prime, T.A., Griffin, J.L., Masoodi, M., Vidal-Puig, A., Murphy, M.P., Bennett, M.R., The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice. Free Radic. Biol. Med. 52 (2012), 841–849.
39. [39] Mezzano, S., Aros, C., Droguett, A., Burgos, M.E., Ardiles, L., Flores, C., Schneider, H., Ruiz-Ortega, M., Egido, J., NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol. Dial. Transpl. 19 (2004), 2505–2512.
40. [40] Hofmann, M.A., Schiekofer, S., Isermann, B., Kanitz, M., Henkels, M., Joswig, M., Treusch, A., Morcos, M., Weiss, T., Borcea, V., Abdel Khalek, A.K., Amiral, J., Tritschler, H., Ritz, E., Wahl, P., Ziegler, R., Bierhaus, A., Nawroth, P.P., Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia 42 (1999), 222–232.
41. [41] Benzler, J., Ganjam, G.K., Pretz, D., Oelkrug, R., Koch, C.E., Legler, K., Stöhr, S., Culmsee, C., Williams, L.M., Tups, A., Central inhibition of IKKβ/NF-κB signaling attenuates high-fat diet-induced obesity and glucose intolerance. Diabetes 64 (2015), 2015–2027.
42. [42] Lewis, P., Stefanovic, N., Pete, J., Calkin, A.C., Giunti, S., Thallas-Bonke, V., Jandeleit-Dahm, K.A., Allen, T.J., Kola, I., Cooper, M.E., de Haan, J.B., Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice. Circulation 115 (2007), 2178–2187.
43. [43] Lim, S., Rashid, M.A., Jang, M., Kim, Y., Won, H., Lee, J., Woo, J.T., Kim, Y.S., Murphy, M.P., Ali, L., Ha, J., Kim, S.S., Mitochondria-targeted antioxidants protect pancreatic β-cells against oxidative stress and improve insulin secretion in glucotoxicity and glucolipotoxicity. Cell Physiol. Biochem. 28 (2011), 873–886.